Delivery Order SPE2DB25D2204-SPE2DB25FTGKP

Award Date 4/30/25
Potential Completion Date 5/1/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,345.50 firm fixed-price delivery order is for the supply of 4,564,783,446 units of the antibiotic medication moxifloxacin hydrochloride 400 mg tablets. The contract has a completion date of June 4, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,566,364,958 tablets of the antibiotic medication moxifloxacin hydrochloride 400 mg. The $22,742.47 firm-fixed-price delivery order contract has a completion date of November 8, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,563,954,858 units of Moxifloxacin HCL 400 mg tablets. This $1,011.77 firm fixed price award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceuticals...
This federal contract award, valued at $2,792.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of moxifloxacin hydrochloride 400 mg tablets, a medication used to treat certain bacterial infections. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,767.45, is for the delivery of 4,562,229,924 units of moxifloxacin hydrochloride 400 mg tablets. The order was placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC...
This is a $1,419.05 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,063,062 tablets of the antibiotic moxifloxacin hydrochloride 400 mg, with a completion date of December 12, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4,567,320,273 units of the pharmaceutical product Moxifloxacin HCL 400 mg Tablet. The award was made by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 20, 2025. The contract is a Delivery Order with a Firm Fixed Price of $2,691.00 and a completion date of February 21, 2025. The contract does not have a set-aside designation. Amerisourcebergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $59,726.47 firm fixed-price delivery order is for the supply of 4,565,213,771 units of Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of July 23, 2024 and was awarded on July 22, 2024 with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,127.06 contract is for the delivery of 4,567,919,068 units of the antibiotic Moxifloxacin HCL 400 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,585.38 firm fixed-price delivery order is for the supply of Moxifloxacin Hydrochloride, a broad-spectrum antibiotic medication. The contract has an ultimate completion date of February 7, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB25D2204
    Indefinite Delivery Contract
  • SPE2DB25D2204-SPE2DB25FTGKP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,285.44 firm fixed-price delivery order is for the supply of 4,568,092,674 units of the antibiotic medication Moxifloxacin Hydrochloride 400 mg Tablets. The award is not set aside and is part of a larger indefinite delivery contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with DLA Troop Support Medical. This IDC enables the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard, through multiple delivery orders. The contract has an ultimate completion date of May 1, 2025.

Generated 8/3/25, 1:06 AM